DK205388A - Stjerneesksplosionskonjugater og fremgangsmaade tilfremstilling deraf samt deres anvendelse - Google Patents

Stjerneesksplosionskonjugater og fremgangsmaade tilfremstilling deraf samt deres anvendelse

Info

Publication number
DK205388A
DK205388A DK205388A DK205388A DK205388A DK 205388 A DK205388 A DK 205388A DK 205388 A DK205388 A DK 205388A DK 205388 A DK205388 A DK 205388A DK 205388 A DK205388 A DK 205388A
Authority
DK
Denmark
Prior art keywords
conjugates
procedures
star explosion
explosion
star
Prior art date
Application number
DK205388A
Other languages
English (en)
Other versions
DK174053B1 (da
DK205388D0 (da
Inventor
Donald A Tomalia
Donald A Kaplan
William J Kruper
Roberta C Cheng
Ian A Tomlinson
Michael J Fazio
David M Hedstrand
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25407923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK205388(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of DK205388D0 publication Critical patent/DK205388D0/da
Publication of DK205388A publication Critical patent/DK205388A/da
Application granted granted Critical
Publication of DK174053B1 publication Critical patent/DK174053B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A01N25/10—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/595—Polyamides, e.g. nylon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
    • A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/48—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules
    • C08G83/003—Dendrimers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/005—Dendritic macromolecules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Environmental Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polyamides (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Luminescent Compositions (AREA)
DK198802053A 1986-08-18 1988-04-14 Stjerneesksplosionskonjugater, fremgangsmåder til fremstilling deraf, fremgangsmåde til fremstilling af en stjerneeksplosionspolyethylenimin og fremgangsmåde til rensning af en stjerneeksplosionsdendrimer DK174053B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89745586A 1986-08-18 1986-08-18
US89745586 1986-08-18
PCT/US1987/002074 WO1988001178A1 (en) 1986-08-18 1987-08-18 Starburst conjugates
US8702074 1987-08-18

Publications (3)

Publication Number Publication Date
DK205388D0 DK205388D0 (da) 1988-04-14
DK205388A true DK205388A (da) 1988-06-14
DK174053B1 DK174053B1 (da) 2002-05-13

Family

ID=25407923

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198802053A DK174053B1 (da) 1986-08-18 1988-04-14 Stjerneesksplosionskonjugater, fremgangsmåder til fremstilling deraf, fremgangsmåde til fremstilling af en stjerneeksplosionspolyethylenimin og fremgangsmåde til rensning af en stjerneeksplosionsdendrimer

Country Status (21)

Country Link
EP (1) EP0271180B2 (da)
JP (6) JPH072840B2 (da)
KR (1) KR970011151B1 (da)
AT (1) ATE89743T1 (da)
AU (2) AU609051B2 (da)
BR (3) BR8707433A (da)
DE (1) DE3786000T3 (da)
DK (1) DK174053B1 (da)
ES (1) ES2054678T5 (da)
FI (2) FI103410B (da)
GR (1) GR3024215T3 (da)
HK (1) HK54396A (da)
HU (2) HU209252B (da)
IE (1) IE61356B1 (da)
IL (1) IL83567A (da)
MX (1) MX169992B (da)
MY (1) MY102878A (da)
NO (1) NO176306C (da)
NZ (1) NZ221484A (da)
WO (3) WO1988001178A1 (da)
ZA (1) ZA876114B (da)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5560929A (en) * 1986-08-18 1996-10-01 The Dow Chemical Company Structured copolymers and their use as absorbents, gels and carriers of metal ions
US5914095A (en) * 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
US5292868A (en) * 1989-05-26 1994-03-08 Akzo N.V. Chelating agents for attaching metal ions to proteins
US5808003A (en) * 1989-05-26 1998-09-15 Perimmune Holdings, Inc. Polyaminocarboxylate chelators
WO1990014881A2 (en) * 1989-05-26 1990-12-13 Akzo N.V. Chelating agents for attaching metal ions to proteins
DE3930674A1 (de) * 1989-09-11 1991-03-21 Diagnostikforschung Inst Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie
DE3938992A1 (de) 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
GB9021671D0 (en) * 1990-10-05 1990-11-21 Unilever Plc Delivery of agents
AU642980B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Ultilization of enzymes
AU641736B2 (en) * 1990-03-21 1993-09-30 Quest International B.V. Delivery of agents
AU642979B2 (en) * 1990-03-21 1993-11-04 Quest International B.V. Utilization and delivery of enzymes
IL99234A (en) * 1990-08-27 1994-05-30 Michigan Molecular Inst Non-cross-linked multi-branch polymers and their preparation
GB9112536D0 (en) * 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds
FR2688508A1 (fr) * 1992-03-13 1993-09-17 Guerbet Sa Nouveau produit de contraste iode, son procede de preparation et son utilisation comme agent de contraste.
US5871713A (en) * 1991-12-04 1999-02-16 Guerbet S.A. Macromolecular polyamine iodine-containing compound, process for its preparation and its use as a contrast agent
AU3354993A (en) * 1991-12-04 1993-06-28 Guerbet S.A. Novel macromolecular polyamine iodine-containing compound, process for its preparation and its use as a contrast agent
DE69312700T2 (de) 1992-04-14 1998-02-19 Cornell Res Foundation Inc Makromoleküle auf basis von dendritischen polymeren und verfahren zur herstellung
US5387617A (en) * 1993-01-22 1995-02-07 The Dow Chemical Company Small cell foams and blends and a process for their preparation
US6121056A (en) * 1993-02-24 2000-09-19 Dade Behring Inc. Random detection of antigens with antibodies immobilized on soluble submicron particles
AU6267794A (en) * 1993-02-24 1994-09-14 Dade International Inc. Immobilization of specific binding assay reagents
US5898005A (en) * 1993-02-24 1999-04-27 Dade Behring Inc. Rapid detection of analytes with receptors immobilized on soluble submicron particles
FR2703055B1 (fr) * 1993-03-22 1995-07-07 Guerbet Sa Nouveaux composés polyiodés, leur préparation et leur utilisation en tant que produits de contraste pour la radiologie .
KR100361933B1 (ko) 1993-09-08 2003-02-14 라 졸라 파마슈티칼 컴파니 화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
US7097839B1 (en) 1993-10-26 2006-08-29 Thomas Jefferson University ST receptor binding compounds and methods of using the same
AU750411B2 (en) * 1994-03-07 2002-07-18 Dendritic Nanotechnologies, Inc. Bioactive and/or targeted dendrimer conjugates
IL128774A (en) * 1994-03-07 2001-05-20 Dow Chemical Co Composition comprising a dendritic poymer in complex with at least one unit of biological response modifier and a process for the preparation thereof
GB9407812D0 (en) * 1994-04-20 1994-06-15 Nycomed Salutar Inc Compounds
NL9400880A (nl) * 1994-05-27 1996-01-02 Dsm Nv Samenstelling bestaande uit een dendrimeer en een in het dendrimeer opgesloten actieve stof, een werkwijze voor de bereiding van een dergelijke samenstelling en een werkwijze voor het vrijstellen van de actieve stof.
NL9401886A (nl) * 1994-05-27 1996-01-02 Dsm Nv Samenstelling bestaande uit een dendrimeer en een in het dendrimeer opgesloten actieve stof, een werkwijze voor de bereiding van een dergelijke samenstelling en een werkwijze voor het vrijgeven van de actieve stof.
AUPM623994A0 (en) 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
WO1996019240A1 (en) * 1994-12-21 1996-06-27 Novartis Ag Oligonucleotide-dendrimer conjugates
FR2734268B1 (fr) * 1995-05-19 1997-07-04 Centre Nat Rech Scient Nouveaux dendrimeres fonctionnels a terminaisons phosphorees et leur procede de preparation
US6051429A (en) 1995-06-07 2000-04-18 Life Technologies, Inc. Peptide-enhanced cationic lipid transfections
US6083708A (en) * 1995-08-11 2000-07-04 Dade Behring Inc. Polypeptide: dendrimer complexes
US5658574A (en) * 1995-10-13 1997-08-19 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cleansing compositions with dendrimers as mildness agents
NL1001753C2 (nl) * 1995-11-28 1997-05-30 Dsm Nv Samenstelling omvattende een kunststof en een additief.
DE19625982A1 (de) * 1996-06-28 1998-01-02 Wella Ag Kosmetisches Mittel zur Haarbehandlung mit Dendrimeren
JP4233117B2 (ja) * 1997-01-13 2009-03-04 住友化学株式会社 樹枝状ポリマーのナノコンポジット
WO1998056427A1 (en) * 1997-06-12 1998-12-17 Mitsubishi Chemical Corporation Novel contrast media
DE19728954C1 (de) * 1997-06-30 1999-04-22 Schering Ag Saccharid-Konjugate, diese enthaltende pharmazeutische Mittel, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2790642A1 (fr) * 1999-03-08 2000-09-15 Aventis Cropscience Sa Nouvelles compositions pesticides et/ou regulatrices de croissance
AU5522600A (en) * 1999-06-29 2001-01-22 Dako A/S Detection using dendrimers bearing labels and probes
PL353336A1 (en) 1999-07-29 2003-11-17 Epix Medical, Inc. Targeting multimeric imaging agents through multilocus binding
FI19991705L (fi) * 1999-08-11 2001-02-12 Neste Chemicals Oy Antimikrobinen hyperhaaroittunut polymeerikoostumus
FR2797563A1 (fr) * 1999-08-18 2001-02-23 Rhodianyl Composes biocides et leur utilisation dans des polymeres thermoplastiques
NZ519462A (en) * 1999-12-10 2004-03-26 Gerald M Rosen Use of poly-nitroxyl-functionalized dendrimers as contrast enhancing agents in MRI imaging of joints
BR0109886B1 (pt) 2000-04-07 2011-10-04 método para inibir a obstrução de um conduto.
US6471968B1 (en) * 2000-05-12 2002-10-29 Regents Of The University Of Michigan Multifunctional nanodevice platform
CU23011A1 (es) * 2000-11-03 2004-12-17 Ct Ingenieria Genetica Biotech Método de obtención de estructuras antigénicas quemétodo de obtención de estructuras antigénicas que potencian la reactividad cruzada específica y su potencian la reactividad cruzada específica y su uso en formulaciones uso en formulaciones
US7122113B2 (en) 2001-06-14 2006-10-17 Shell Oil Company Method for solubilising asphaltenes in a hydrocarbon mixture
TWI221406B (en) 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
GB0209022D0 (en) 2002-04-19 2002-05-29 Imp College Innovations Ltd Compounds
US7696393B2 (en) 2002-09-03 2010-04-13 Shell Oil Company Method and compositions for inhibiting formation of hydrocarbon hydrates
EP1525890A1 (en) 2003-10-02 2005-04-27 Complex Biosystems GmbH Protein-Proteophore complexes
EP2264191A1 (en) * 2003-11-21 2010-12-22 ANP Technologies, Inc. Asymmetrically branched polymer conjugates and microarray assays
ES2547220T3 (es) 2004-04-20 2015-10-02 Dendritic Nanotechnologies, Inc. Polímeros dendríticos con amplificación y funcionalidad interior mejoradas
US7985424B2 (en) 2004-04-20 2011-07-26 Dendritic Nanotechnologies Inc. Dendritic polymers with enhanced amplification and interior functionality
WO2006016665A1 (ja) 2004-08-13 2006-02-16 Nippon Soda Co., Ltd. 多分岐ポリマー及びその製造方法
CA2578205A1 (en) * 2004-08-25 2006-03-30 The Regents Of The University Of Michigan Partially acetylated dendrimers and related methods of use
EP1656840B1 (en) 2004-11-08 2008-05-14 FUJIFILM Corporation Use of an active oxygen eliminator
CA2590495C (en) 2004-11-24 2013-09-03 Shell Canada Limited Method for improving the flowability of a mixture that contains wax and other hydrocarbons
EP1877103A4 (en) * 2005-04-20 2010-11-03 Dendritic Nanotechnologies Inc DENDRITIC POLYMERS WITH IMPROVED AMPLIFICATION AND INNER FUNCTIONALITY
US7575687B2 (en) * 2005-08-16 2009-08-18 Ge Osmonics, Inc. Membranes and methods useful for caustic applications
CN101258184B (zh) 2005-09-07 2012-05-23 日本曹达株式会社 星形聚合物及其制造方法
CN103071209A (zh) 2005-11-17 2013-05-01 周吉尼克斯股份有限公司 用无针注射递送粘稠制剂
CN101906195B (zh) 2006-07-11 2014-01-08 日本曹达株式会社 星形聚合物及其制造方法
US20080020043A1 (en) * 2006-07-20 2008-01-24 Marc Gingras Dendrimer-Drug Conjugates
US8268347B1 (en) 2006-10-24 2012-09-18 Aradigm Corporation Dual action, inhaled formulations providing both an immediate and sustained release profile
US8658148B2 (en) 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
CN101784575B (zh) 2007-08-31 2012-06-20 日本曹达株式会社 星形聚合物的制造方法
WO2009151687A2 (en) 2008-03-12 2009-12-17 The Regents Of The University Of Michigan Dendrimer conjugates
ES2563061T3 (es) 2008-04-28 2016-03-10 Zogenix, Inc. Nuevas formulaciones para el tratamiento de la migraña
WO2010039861A2 (en) 2008-09-30 2010-04-08 The Regents Of The University Of Michigan Dendrimer conjugates
US9017644B2 (en) 2008-11-07 2015-04-28 The Regents Of The University Of Michigan Methods of treating autoimmune disorders and/or inflammatory disorders
CA2777682C (en) 2009-10-13 2015-02-24 The Regents Of The University Of Michigan Dendrimer compositions and methods of synthesis
CN102781231B (zh) * 2009-10-26 2014-12-24 德瑞迪克纳米科技公司 用于农业中的peham树枝状化合物
US8912323B2 (en) 2009-10-30 2014-12-16 The Regents Of The University Of Michigan Multifunctional small molecules
EP2540311A4 (en) * 2010-02-26 2016-07-06 Univ Nagasaki COMPOSITE BODY FOR THE ADMINISTRATION OF ANTIGENES OR MEDICINES
WO2013085718A1 (en) 2011-12-08 2013-06-13 The Regents Of The University Of Michigan Multifunctional small molecules
US9921205B2 (en) 2012-11-13 2018-03-20 Chevron U.S.A. Inc. Method for determining the effectiveness of asphaltene dispersant additives for inhibiting or preventing asphaltene precipitation in a hydrocarbon-containing material subjected to elevated temperature and presssure conditions
GB201405660D0 (en) * 2014-03-28 2014-05-14 Gama Healthcare Ltd A liquid disinfecting composition
US10981858B2 (en) * 2015-12-16 2021-04-20 Priostar Pty Ltd Dendrimer and formulations thereof
US10907473B2 (en) 2017-11-14 2021-02-02 Chevron U.S.A., Inc. Low volume in-line filtration methods for analyzing hydrocarbon-containing fluid to evaluate asphaltene content and behavior during production operations
CN109287624A (zh) * 2018-10-08 2019-02-01 威海晨源分子新材料有限公司 一种树枝状聚酰胺-胺在农药中的应用
JP2022517193A (ja) 2019-01-03 2022-03-07 アイオンパス， インク． イオンビームイメージングのための組成物および試薬
JP7436838B2 (ja) * 2020-05-20 2024-02-22 藤倉化成株式会社 抗体－デンドリマー複合体を用いるヘモグロビンＡ１ｃの測定方法
CN114292217A (zh) * 2021-12-31 2022-04-08 安源基因科技(上海)有限公司 生物活性交联剂、生物交联物、试剂盒及应用
GB202412414D0 (en) 2024-08-23 2024-10-09 Univ Bradford Methods for treating cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289872A (en) * 1979-04-06 1981-09-15 Allied Corporation Macromolecular highly branched homogeneous compound based on lysine units
IL64277A0 (en) * 1981-11-11 1982-02-28 Basht Ltd Apparatus for removal of integrated circuits from circuit boards
GB2122641B (en) * 1982-06-07 1986-08-06 Otto A Gansow Metal chelate conjugated monoclonal antibodies where in the metal is an emitter
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4631337A (en) * 1983-01-07 1986-12-23 The Dow Chemical Company Hydrolytically-stable dense star polyamine
US4558120A (en) * 1983-01-07 1985-12-10 The Dow Chemical Company Dense star polymer
US4507466A (en) * 1983-01-07 1985-03-26 The Dow Chemical Corporation Dense star polymers having core, core branches, terminal groups
US4606907A (en) * 1984-07-02 1986-08-19 The Dow Chemical Company Bone seeking Tc-99m complexes of phosphonate derivatives of polyamidoamines
US4599400A (en) * 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
US4694064A (en) * 1986-02-28 1987-09-15 The Dow Chemical Company Rod-shaped dendrimer

Also Published As

Publication number Publication date
JPS63502350A (ja) 1988-09-08
DE3786000T3 (de) 1997-08-21
HK54396A (en) 1996-04-03
GR3024215T3 (en) 1997-10-31
DE3786000T2 (de) 1993-09-02
ES2054678T3 (es) 1994-08-16
JPH06220190A (ja) 1994-08-09
IL83567A (en) 1992-02-16
JPH069778A (ja) 1994-01-18
JPS63501876A (ja) 1988-07-28
EP0271180B1 (en) 1993-05-26
HU209252B (en) 1994-04-28
NO176306C (no) 1995-03-15
FI881768L (fi) 1988-04-15
FI981807L (fi) 1998-08-24
AU8139191A (en) 1991-10-03
EP0271180B2 (en) 1997-06-18
NO176306B (no) 1994-12-05
BR8707433A (pt) 1988-11-01
ZA876114B (en) 1989-04-26
JPH0757736B2 (ja) 1995-06-21
NO881639D0 (no) 1988-04-15
ATE89743T1 (de) 1993-06-15
HU9303379D0 (en) 1994-03-28
DK174053B1 (da) 2002-05-13
JPH07108860B2 (ja) 1995-11-22
IL83567A0 (en) 1988-01-31
JPH06219966A (ja) 1994-08-09
JP2848218B2 (ja) 1999-01-20
HU220205B (hu) 2001-11-28
KR970011151B1 (ko) 1997-07-07
WO1988001180A1 (en) 1988-02-25
FI103410B1 (fi) 1999-06-30
IE61356B1 (en) 1994-11-02
KR880701564A (ko) 1988-11-03
WO1988001178A1 (en) 1988-02-25
BR8707432A (pt) 1988-11-01
FI981807A0 (fi) 1998-08-24
AU638153B2 (en) 1993-06-17
BR8707431A (pt) 1988-11-01
JP2771404B2 (ja) 1998-07-02
WO1988001179A1 (en) 1988-02-25
EP0271180A1 (en) 1988-06-15
JPH0757735B2 (ja) 1995-06-21
DE3786000D1 (de) 1993-07-01
AU609051B2 (en) 1991-04-26
FI103410B (fi) 1999-06-30
DK205388D0 (da) 1988-04-14
FI105693B (fi) 2000-09-29
MY102878A (en) 1993-03-31
IE872210L (en) 1988-02-18
ES2054678T5 (es) 1997-09-16
MX169992B (es) 1993-08-04
NZ221484A (en) 1991-01-29
HUT55245A (en) 1991-05-28
JPS63501878A (ja) 1988-07-28
AU7715987A (en) 1988-03-03
JPH072840B2 (ja) 1995-01-18
FI881768A0 (fi) 1988-04-15
NO881639L (no) 1988-06-15

Similar Documents

Publication Publication Date Title
DK205388D0 (da) Stjerneesksplosionskonjugater og fremgangsmaade tilfremstilling deraf samt deres anvendelse
DE3883112D1 (de) Chirurgisches instrument mit verstellbarem operationswinkel.
NO881460D0 (no) Kumaapning i veibane.
FI892377A0 (fi) Ny polymerkomposition.
ATE88898T1 (de) Cd4-polypeptidderivate.
NO913302D0 (no) Anti-fungale triazolderivater, samt fremstilling og anvendelse derav.
NO903169D0 (no) 4,1,2-1h-benzoksadiaziner og deres fremstilling.
NO892869D0 (no) Heteropolysakkarider, fremgangsmaate for deres fremstilling og anvendelse.
FI893279A0 (fi) Antivirusmedel samt kompositioner innehaollande desamma.
DE68913915D1 (de) Hitzebeständige und schlagfeste Harzzusammensetzung.
NO901629D0 (no) Vandige plastdispersjoner, deres fremstilling og anvendelse.
NO895187L (no) Polymerblanding.
NO895089L (no) Polymerblandinger og fremgangsmaate for deres fremstilling.
NO892190L (no) Kompositt-materialer og deres anvendelse.
DE68906427D1 (de) Propan-derivate.
DK396089A (da) 6-aroyl-substituerede 3,4-dihydro-2h-benzopyraner samt fremstilling og anvendelse deraf
IT1216668B (it) Perfezionamenti nei dispositivi protettori elettrotermici.
ATE102224T1 (de) Modifizierte polytetrafluoraethylenharze und damit hergestellte zusammensetzungen.
DK185389A (da) 3,5-substituerede 1,2,4-oxadiazoler, deres fremstiling og anvendelse

Legal Events

Date Code Title Description
PUP Patent expired